• Budesonide in Pulmonary Drug Permeability: Scientific Advanc

  2026-04-22

  Explore how Budesonide, a leading anti-inflammatory corticosteroid, enables next-generation pulmonary drug permeability assays. This article uniquely connects biomimetic chromatography insights with practical guidance for respiratory inflammation research.

• Novel Culture Paradigm Extends Mouse Corneal Epithelial Prol

  2026-04-21

  An X et al. present a feeder-free, serum-free 6C medium containing small-molecule modulators—including IWP-2—enabling prolonged proliferation and maintenance of mouse corneal epithelial cells (mCEC) in vitro and in vivo. This approach advances corneal regenerative research by suppressing epithelial-mesenchymal transdifferentiation and improving the harvest of progenitor cells for transplantation applications.

• MCC950 Sodium in Endothelial Pyroptosis: Precision Tools for

  2026-04-21

  Explore the advanced application of MCC950 sodium in dissecting pyroptosis and vascular inflammation, with a focus on endothelial cell dysfunction in atherosclerosis. This article uniquely integrates mechanistic insights, protocol guidance, and translational value for inflammatory disease research.

• Methotrexate: Folate Antagonist Mechanisms & Research Protoc

  2026-04-20

  Methotrexate is a folate antagonist that inhibits dihydrofolate reductase (DHFR), blocking DNA synthesis and cell proliferation. It is widely used as an immunosuppressive and anti-inflammatory agent in research. Robust evidence supports its utility in apoptosis induction and permeability profiling.

• Actin–Myosin II Network Regulates DEV Proliferation via VP26

  2026-04-20

  This study identifies host actin–myosin II cytoskeletal proteins as critical interactors of the duck enteritis virus (DEV) protein VP26, revealing that disruption of this network reduces viral proliferation. The findings offer mechanistic insight into DEV-host interactions and highlight actin polymerization inhibitors like Latrunculin A as useful tools for dissecting cytoskeletal roles in viral infection.

• Ceruletide in Pancreatic Function Research: Protocols & Insi

  2026-04-19

  Ceruletide enables robust, reproducible modeling of pancreatic fibrosis and gastrointestinal motility—critical for translational digestive disease research. This guide bridges recent advances in MFGE8-targeted fibrosis pathways with practical workflows, protocol enhancements, and troubleshooting tips, all leveraging APExBIO’s high-purity synthetic decapeptide.

• LGK-974: Precision PORCN Inhibitor for Wnt Pathway Research

  2026-04-18

  LGK-974 enables precise, low-cytotoxicity modulation of the Wnt/β-catenin pathway—advancing studies in pancreatic cancer, RNF43-mutant models, and β-catenin-driven tumor regression. This guide translates cutting-edge evidence and real-world troubleshooting into actionable protocols for superior reproducibility and translational insight.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Insig

  2026-04-17

  The referenced study establishes moesin (MSN) as a novel biomarker that reflects the severity of endothelial injury in sepsis, correlating with established clinical indices and experimental markers of vascular damage. This finding opens avenues for more precise assessment and mechanistic study of endothelial dysfunction in sepsis, with implications for translational research on vascular permeability and inflammation.

• Scenario-Driven Best Practices Using GSK2606414 (SKU A3448)

  2026-04-16

  This article delivers evidence-based guidance for deploying GSK2606414 (SKU A3448) as a selective PERK inhibitor in ER stress research. Through five scenario-based Q&A blocks, it addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how GSK2606414 ensures reliability and reproducibility. Practical workflow recommendations and quantitative literature data are integrated for translational researchers.

• Tamsulosin for Preventing Postoperative Urinary Retention: S

  2026-04-14

  Explore the latest meta-analytic evidence on Tamsulosin, a selective α1A-adrenergic receptor antagonist, in reducing postoperative urinary retention. This article delivers advanced, protocol-ready insights for translational researchers, distinct from prior content.

• Grazoprevir Hydrate: Advanced Protocols and Clinical Insight

  2026-04-13

  Explore the scientific foundation of Grazoprevir hydrate, a potent HCV NS3/4A protease inhibitor. This article delivers unique, protocol-focused insights for hepatitis C virus replication inhibition, emphasizing practical assay design and clinical translation.

• IWR-1-endo: Wnt Signaling Inhibitor for Advanced Cancer Rese

  2026-04-13

  IWR-1-endo stands out as a potent Wnt signaling inhibitor, enabling precise modulation of the Wnt/β-catenin pathway in both in vitro and in vivo settings. Its unique mechanism—Axin-scaffolded destruction complex stabilization—empowers breakthrough studies in colorectal cancer and regenerative models, with reproducible workflows and robust protocol guidance.

• Baicalin: Unlocking Neuroplasticity & Cancer Pathway Modulat

  2026-04-12

  Baicalin, a high-purity flavone glycoside from Scutellaria baicalensis, is redefining translational research boundaries. By precisely modulating the KEAP1-NRF2/HO-1 and TGF-β1/p-Smad3 pathways, it offers robust solutions in neuroplasticity and oncology. This article bridges mechanistic insight, preclinical evidence, and workflow strategy, providing translational researchers with actionable guidance that goes far beyond conventional reagent descriptions. Key findings on adult visual plasticity restoration and cancer sensitization highlight Baicalin’s dual-domain value. Protocol parameters, workflow tips, and a critical perspective on cross-domain application maturity are included for maximum bench-to-bedside utility.

• CHIR-99021 (CT99021): Strategic Leverage in Stem Cell Transl

  2026-04-12

  Explore how CHIR-99021 (CT99021) reshapes the boundaries of pluripotency maintenance, directed differentiation, and translational innovation. This thought-leadership article blends mechanistic insight into Wnt/β-catenin signaling and GSK-3 inhibition with actionable guidance for stem cell researchers, referencing the latest discoveries in genome regulation and highlighting APExBIO’s product advantages.

• Angiotensin 1/2 (1-6): Precision Tool for Renin-Angiotensin

  2026-04-11

  Angiotensin 1/2 (1-6) empowers researchers with high-purity, workflow-ready modulation of vascular and renal signaling, streamlining cardiovascular and viral pathophysiology research. APExBIO’s rigorously characterized peptide stands out for exceptional solubility and assay reproducibility, enabling nuanced exploration of the renin-angiotensin axis across disciplines.

15636 records 1/1043 page Next 12345 下5页 Last page